Showing results (281-290 of 483) with videos related to

Sort By:
Pageof 49
Sexually Transmitted Diseases|April 25, 2024
Insights Into Treatment Alternatives for Neurosyphilis: Systematic Literature Review and Meta-AnalysisGustavo Yano Callado, Isabele Pardo, Maria Celidonio Gutfreund, et al.
Neurotoxicology|February 29, 2000
Neurotoxicity evaluation of rats after subchronic inhalation exposure to isobutanolA A Li, D C Thake, T A Kaempfe, et al.
European Journal of Internal Medicine|December 14, 2021
Pulmonary embolism - An EFIM guideline critical appraisal and adaptation for practicing cliniciansCecilia Becattini, Valentin A Kokorin, Wiktoria Lesniak, et al.
Diabetes Research and Clinical Practice|September 6, 2005
Interleukin-6-174 G > C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patientsR Testa, F Olivieri, A R Bonfigli, et al.
Brain : a Journal of Neurology|June 30, 2022
Neuropathic pain correlates with worsening cognition in people with human immunodeficiency virusRonald J Ellis, Ned Sacktor, David B Clifford, et al.
Molecular Genetics and Metabolism|February 6, 2008
+647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complicationsR Giacconi, A R Bonfigli, R Testa, et al.
European Annals of Allergy and Clinical Immunology|March 18, 2026
Regional disparities in access to epinephrine auto-injectors for children and adults in ItalyA Klain, B Yang, L Cecchi, et al.
Nature Communications|July 24, 2019
Genomic epidemiology of syphilis reveals independent emergence of macrolide resistance across multiple circulating lineagesMathew A Beale, Michael Marks, Sharon K Sahi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2000
A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individualsC M Marra, P Boutin, J C McArthur, et al.
Current Cancer Drug Targets|June 11, 2009
Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathwaysM Caraglia, M Marra, P Tagliaferri, et al.
Pageof 49